Soft Tissue Sarcomas: Treatment and Management
Due to the rarity and heterogeneity of soft tissue sarcoma, investigation into new treatments and methods of management has been challenging. Although intensive chemotherapy and the establishment of surgical procedures have improved the outcome of patients with soft tissue sarcomas, there remains limited options of anticancer agents, a high incidence of postoperative complications, and an unsatisfactory curative rate for recurrent and metastatic soft tissue sarcomas. The Special Issue aims to bring together the highest quality original/review articles on basic and clinical research into soft tissue sarcomas. Papers on molecular biology, the microenvironment, anticancer agents, and the management of soft tissue sarcomas are welcome.
Dr. Shinji Miwa
Dr. Po-Kuei Wu
Dr. Hiroyuki Tsuchiya
- soft tissue sarcoma
|Journal Name||Impact Factor||CiteScore||Launched Year||First Decision (median)||APC|
|4.2||4.0||2012||18.8 Days||CHF 2700|
|5.2||7.4||2009||18.2 Days||CHF 2900|
|2.6||2.6||1994||18.4 Days||CHF 2200|
International Journal of Environmental Research and Public Healthijerph
|-||5.4||2004||22 Days||CHF 2500|
|-||-||2021||15.0 days *||CHF 1000|
* Median value for all MDPI journals in the first half of 2023.
Preprints is a platform dedicated to making early versions of research outputs permanently available and citable. MDPI journals allow posting on preprint servers such as Preprints.org prior to publication. For more details about reprints, please visit https://www.preprints.org.